• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据Toll样受体4(Asp299Gly)基因多态性比较埃及新冠肺炎患者的特征

Comparison of COVID-19 characteristics in Egyptian patients according to their Toll-Like Receptor-4 (Asp299Gly) polymorphism.

作者信息

Taha Sara I, Shata Aalaa K, El-Sehsah Eman M, Mohamed Manar F, Moustafa Nouran M, Youssef Mariam K

机构信息

Department of Clinical Pathology/Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Department of Pulmonary Medicine, Faculty of Medicine, Ain Shams university, Cairo, Egypt.

出版信息

Infez Med. 2022 Mar 1;30(1):96-103. doi: 10.53854/liim-3001-11. eCollection 2022.

DOI:10.53854/liim-3001-11
PMID:35350262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8929736/
Abstract

BACKGROUND

Toll-like receptor (TLR)-4 plays a vital role in recognizing viral particles, activating the innate immune system, and producing pro-inflammatory cytokines.

OBJECTIVES

This cross-sectional study aimed to compare COVID-19 severity, progression, and fate according to TLR-4 (Asp299Gly) polymorphism in Egyptian patients.

METHODS

A total of 145 COVID-19 patients were included in this study. TLR-4 (Asp299Gly) genotyping was done using the PCR restriction fragment length polymorphism (PCR-RFLP) approach.

RESULTS

The most commonly encountered TLR-4 genotype in relation to the amino acid at position 299 was the wild-type AA (73.1%); meanwhile, the homozygous mutant GG genotype (8.3%) was the least encountered. At hospital admission, 85.8% of the AA group had free (with no ground glass opacities) chest computed tomography (CT) examination, and 16.0% were asymptomatic. On the other hand, of the AG and GG groups, 81.5% and 83.3%, respectively showed bilateral ground-glass opacities in chest CT, as well as 25.9% and 75.0%, respectively were dyspneic. Values of the total leucocytic count, C-reactive protein (CRP), ferritin, and D dimer increased in the AA<AG<GG sequence. In contrast, hemoglobin values and the absolute lymphocyte counts decreased in the AA>AG>GG sequence. ICU admission (83.3%) and in-hospital death (33.3%) rates were significantly higher in the GG group.

CONCLUSIONS

In COVID-19 patients, the TLR-4 mutant G allele may be associated with a more aggressive disease course and in-hospital death. New therapeutic alternatives could be aimed at this area.

摘要

背景

Toll样受体(TLR)-4在识别病毒颗粒、激活先天性免疫系统和产生促炎细胞因子方面发挥着至关重要的作用。

目的

本横断面研究旨在根据埃及患者的TLR-4(Asp299Gly)多态性比较新型冠状病毒肺炎(COVID-19)的严重程度、进展情况和转归。

方法

本研究共纳入145例COVID-19患者。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法进行TLR-4(Asp299Gly)基因分型。

结果

与第299位氨基酸相关的最常见TLR-4基因型是野生型AA(73.1%);同时,纯合突变GG基因型(8.3%)是最不常见的。入院时,AA组85.8%的患者胸部计算机断层扫描(CT)检查结果正常(无磨玻璃影),16.0%无症状。另一方面,AG组和GG组分别有81.5%和83.3%的患者胸部CT显示双侧磨玻璃影,分别有25.9%和75.0%的患者出现呼吸困难。总白细胞计数、C反应蛋白(CRP)、铁蛋白和D-二聚体的值在AA<AG<GG序列中升高。相反,血红蛋白值和绝对淋巴细胞计数在AA>AG>GG序列中降低。GG组的重症监护病房(ICU)入住率(83.3%)和院内死亡率(33.3%)显著更高。

结论

在COVID-19患者中,TLR-4突变G等位基因可能与更严重的病程和院内死亡相关。新的治疗方案可针对这一领域。

相似文献

1
Comparison of COVID-19 characteristics in Egyptian patients according to their Toll-Like Receptor-4 (Asp299Gly) polymorphism.根据Toll样受体4(Asp299Gly)基因多态性比较埃及新冠肺炎患者的特征
Infez Med. 2022 Mar 1;30(1):96-103. doi: 10.53854/liim-3001-11. eCollection 2022.
2
Toll-Like Receptor-4 Gene (Asp299Gly) polymorphism in allergic conjunctivitis.变应性结膜炎中 Toll 样受体 4 基因(Asp299Gly)多态性。
Egypt J Immunol. 2022 Jan;29(1):1-12.
3
Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients.Toll样受体4基因多态性(896A/G和1196C/T)作为埃及患者便利样本中COVID-19严重程度的指标
J Inflamm Res. 2021 Nov 27;14:6293-6303. doi: 10.2147/JIR.S343246. eCollection 2021.
4
TLR4 Asp299Gly (rs4986790) polymorphism and coronary artery disease: a meta-analysis.Toll样受体4 Asp299Gly(rs4986790)基因多态性与冠状动脉疾病:一项荟萃分析
PeerJ. 2015 Nov 26;3:e1412. doi: 10.7717/peerj.1412. eCollection 2015.
5
Asp299Gly and Thr399Ile polymorphism of TLR-4 gene in patients with prostate cancer from North India.印度北部前列腺癌患者TLR-4基因的Asp299Gly和Thr399Ile多态性
Indian J Urol. 2013 Jan;29(1):37-41. doi: 10.4103/0970-1591.109982.
6
The potential role of toll-like receptor 4 Asp299Gly polymorphism and its association with recurrent cystic echinococcosis in postoperative patients.Toll样受体4 Asp299Gly多态性在术后复发性囊型棘球蚴病患者中的潜在作用及其相关性
Parasitol Res. 2018 Jun;117(6):1717-1727. doi: 10.1007/s00436-018-5850-6. Epub 2018 Mar 30.
7
Genetic polymorphism ARG753GLN of TLR-2, LEU412PHE of TLR-3, ASP299GLY of TLR-4 in patients with influenza and influenza-associated pneumonia.流感及流感相关性肺炎患者中TLR-2基因的ARG753GLN、TLR-3基因的LEU412PHE、TLR-4基因的ASP299GLY的基因多态性
Wiad Lek. 2019;72(12 cz 1):2324-2328.
8
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in ovarian cancers.卵巢癌中Toll样受体4单核苷酸多态性Asp299Gly和Thr399Ile
Oncol Lett. 2014 Jul;8(1):438-440. doi: 10.3892/ol.2014.2113. Epub 2014 May 7.
9
Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness.与脂多糖低反应性相关的Toll样受体4基因Asp299Gly多态性的简单基因型分析。
J Clin Lab Anal. 2002;16(1):56-8. doi: 10.1002/jcla.2075.
10
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.Toll样受体4基因Asp299Gly多态性与血管炎症减轻、冠状动脉造影显示的冠心病以及临床糖尿病有关。
Am Heart J. 2004 Dec;148(6):1034-40. doi: 10.1016/j.ahj.2004.05.049.

引用本文的文献

1
Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?Toll样受体在新冠后相关神经退行性疾病中的作用?
Front Med (Lausanne). 2025 Mar 26;12:1458281. doi: 10.3389/fmed.2025.1458281. eCollection 2025.
2
Toll-like receptors polymorphisms and COVID-19: a systematic review.Toll样受体基因多态性与2019冠状病毒病:一项系统评价
Mol Cell Biochem. 2025 May;480(5):2677-2688. doi: 10.1007/s11010-024-05137-3. Epub 2024 Nov 9.
3
The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene as a protective factor in corona virus disease 2019 (COVID-19).基因中的单核苷酸多态性rs4986790(c.896A>G)作为2019冠状病毒病(COVID-19)的一个保护因素。
Front Immunol. 2024 Feb 16;15:1355193. doi: 10.3389/fimmu.2024.1355193. eCollection 2024.
4
The SARS-CoV-2 spike S1 protein induces global proteomic changes in ATII-like rat L2 cells that are attenuated by hyaluronan.SARS-CoV-2 刺突蛋白 S1 诱导类似于 ATII 的大鼠 L2 细胞中的全蛋白质组变化,透明质酸可减弱这种变化。
Am J Physiol Lung Cell Mol Physiol. 2023 Apr 1;324(4):L413-L432. doi: 10.1152/ajplung.00282.2022. Epub 2023 Jan 31.
5
Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity.系统评价和荟萃分析人类遗传变异对 COVID-19 易感性和严重程度的影响。
Gene. 2022 Nov 30;844:146790. doi: 10.1016/j.gene.2022.146790. Epub 2022 Aug 17.
6
mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients.2019 年冠状病毒病患者鼻咽部上皮细胞中 Toll 样受体 3、7、8 和 9 的 mRNA 表达。
BMC Infect Dis. 2022 May 10;22(1):448. doi: 10.1186/s12879-022-07437-9.

本文引用的文献

1
Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients.Toll样受体4基因多态性(896A/G和1196C/T)作为埃及患者便利样本中COVID-19严重程度的指标
J Inflamm Res. 2021 Nov 27;14:6293-6303. doi: 10.2147/JIR.S343246. eCollection 2021.
2
Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染与帕金森病之间的潜在联系:Toll样受体4的作用
Int J Mol Sci. 2021 Jul 1;22(13):7135. doi: 10.3390/ijms22137135.
3
Immunopathogenesis and immunobiology of SARS-CoV-2.SARS-CoV-2 的免疫发病机制和免疫生物学。
Infez Med. 2021 Jun 1;29(2):167-180.
4
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.COVID-19 大流行:从起源到结局。对病毒发病机制、临床表现、诊断评估和治疗的全面综述。
Infez Med. 2021 Mar 1;29(1):20-36.
5
COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.COVID-19 相关凝血功能障碍:发病机制及临床意义简述。
Infez Med. 2021 Mar 1;29(1):1-9.
6
Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.Toll样受体4和血管紧张素转换酶2的双重靶向:一种治疗新型冠状病毒肺炎的建议方法。
Future Microbiol. 2021 Mar;16:205-209. doi: 10.2217/fmb-2021-0018. Epub 2021 Feb 11.
7
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.COVID-19 和 Toll 样受体 4(TLR4):SARS-CoV-2 可能结合并激活 TLR4 以增加 ACE2 的表达,从而促进进入并导致过度炎症。
Mediators Inflamm. 2021 Jan 14;2021:8874339. doi: 10.1155/2021/8874339. eCollection 2021.
8
Baseline characteristics of COVID-19 Italian patients admitted to Desio Hospital, Lombardy: a retrospective study.伦巴第大区德西奥医院收治的新冠肺炎意大利患者的基线特征:一项回顾性研究。
Scand J Clin Lab Invest. 2021 Feb;81(1):18-23. doi: 10.1080/00365513.2020.1846211. Epub 2021 Jan 6.
9
Toll-like receptors and COVID-19: a two-faced story with an exciting ending.Toll样受体与新型冠状病毒肺炎:一个有着激动人心结局的双面故事。
Future Sci OA. 2020 Jul 30;6(8):FSO605. doi: 10.2144/fsoa-2020-0091.
10
Clinical laboratory characteristics of severe patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.2019年冠状病毒病(COVID-19)重症患者的临床实验室特征:一项系统综述和荟萃分析。
Clin Epidemiol Glob Health. 2021 Jan-Mar;9:184-190. doi: 10.1016/j.cegh.2020.08.012. Epub 2020 Sep 15.